Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifevantage (LFVN) Liabilities and Shareholders Equity (2016 - 2025)

Lifevantage (LFVN) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $61.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 10.74% year-over-year to $61.2 million, compared with a TTM value of $271.9 million through Dec 2025, up 8.09%, and an annual FY2025 reading of $72.0 million, up 19.34% over the prior year.
  • Liabilities and Shareholders Equity was $61.2 million for Q4 2025 at Lifevantage, down from $61.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $78.7 million in Q2 2021 and bottomed at $60.3 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $68.3 million, with a median of $67.7 million recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity surged 43.54% in 2021, then decreased 10.74% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $72.2 million in 2021, then dropped by 6.11% to $67.8 million in 2022, then fell by 7.59% to $62.7 million in 2023, then increased by 9.32% to $68.5 million in 2024, then decreased by 10.74% to $61.2 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for LFVN at $61.2 million in Q4 2025, $61.6 million in Q3 2025, and $72.0 million in Q2 2025.